Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03489460
Other study ID # 17-01591
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 1, 2019
Est. completion date August 1, 2019

Study information

Verified date January 2020
Source NYU Langone Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A pilot study that seeks to develop a set of typologies of users of mobile sleep tracking technologies, and optimal sleep health educational strategies among users of mobile wearable technologies that track sleep.


Recruitment information / eligibility

Status Completed
Enrollment 1060
Est. completion date August 1, 2019
Est. primary completion date August 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria:

- A current user of the OURA ring activity and sleep tracker device.

For Aim 3 MOST message testing, the inclusion criteria include the following:

- Health conscious.

Exclusion Criteria:

- Non English speakers.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Specialized sleep-related message interventions
Over the course of 2 weeks' participants will receive specialized sleep-related message interventions to encourage sleep awareness via the smartphone application.
GAD
Survey responses will be merged with objective GAD data (sleep time, time in deep sleep, physical activity) which will assist in developing message design formats for message testing.

Locations

Country Name City State
United States New York University School of Medicine New York New York

Sponsors (1)

Lead Sponsor Collaborator
NYU Langone Health

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sleep time measured by wearable mobile sleep tracking technology Mobile sleep tracking device will be worn by patient for 15 days and will measure sleep patterns in patients 15 Days
Primary Time in deep sleep measured by wearable mobile sleep tracking technology Mobile sleep tracking device will be worn by patient for 15 days and will measure sleep patterns in patients 15 Days
Primary Dysfunctional Beliefs about Sleep (DBAS) scale 24-item DBAS scale with five subscales corresponding to: (1) consequences of insomnia (2) control and predictability of sleep (3) sleep requirement expectations (5) sleep-promoting practices 1 Day
Primary Measure of motivation to change using the Change Assessment Scale (CAS) 8 scale measure divided into 4 separate scales: Scale 1: "Pre-Contemplation" Scale 2: "Contemplation" Scale 3 "Action" Scale 4 "Maintenance" 15 Days
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06348082 - Project Women's Insomnia Sleep Health Equity Study (WISHES) N/A
Completed NCT03389828 - Qualitative Study of Black-White Sleep Disparities
Recruiting NCT05869734 - Effects of Conservative Management on Relieving Storage Urinary Symptoms and Poor Sleep in Women With Diabetes N/A
Recruiting NCT06311500 - Sleep Health Enhancement in Midlife Adults Phase 1/Phase 2
Completed NCT05368909 - Clinical Study to Assess a Dietary Supplement on Sleep Health and Quality N/A